Search - tctmd.com

Displaying 241 - 260 of 620

Sort: Relevancy | Date

Presentation TCT 2017

Romania Presents: Complications That Can Occur During ACS PCI

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa

October 30, 2017

Presentation TCT 2017

CABG Remains the Gold Standard for Left Main Coronary Artery Disease!

Presenter: Robert A. Guyton

October 30, 2017

Presentation TCT 2017

Debate: Making the Case for Not Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

Presenter: John A. Bittl, Freek W.A. Verheugt, Somjot S. Brar

October 30, 2017

Presentation TCT 2017

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Presenter: Anthony H. Gershlick

October 30, 2017

Presentation TCT 2017

Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

Presenter: John A. Bittl, Freek W.A. Verheugt, Dimitrios Alexopoulos

October 30, 2017

Presentation TCT 2017

NSTEMI Case Presentation: Why the DAPT Pre-load Decision Matters

Presenter: John A. Bittl, Freek W.A. Verheugt, Patricia J. Best

October 30, 2017

Presentation TCT 2017

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Presenter: Thomas H. Maloney, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI/ACS

Presenter: Thomas H. Maloney, Jaya Chandrasekhar

October 30, 2017

Presentation TCT 2017

Should Choice of Parenteral Therapy for Primary PCI in STEMI Depend on Vascular Access?

Presenter: Michael S. Lee, Dirk Sibbing, John A. Bittl

October 30, 2017

Presentation TCT 2017

Case Presentation Introduction: STEMI/ACS

Presenter: Thomas H. Maloney, Jaya Chandrasekhar

October 30, 2017

Presentation TCT 2017

Impact of AUC and Public Reporting: Is PCI Now More Appropriate?

Presenter: Dean J. Kereiakes, Spencer B. King III, Michael A. Kutcher

October 30, 2017

Presentation TCT 2017

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

Presenter: Michael S. Lee, Dirk Sibbing, David Erlinge

October 30, 2017

Presentation TCT 2017

What Is the Next Quality Indicator to Improve Outcomes in STEMI?

Presenter: Thomas H. Maloney, Connie N. Hess

October 30, 2017

Presentation TCT 2017

Why I Use Cangrelor for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Dmitriy N. Feldman

October 30, 2017

Presentation TCT 2017

Why I Prefer Bivalirudin for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Uwe Zeymer

October 30, 2017

Presentation TCT 2017

A CHIP Case Presentation

Presenter: Thomas H. Maloney, Justine Alexander, Sheila Sahni

October 30, 2017

Presentation TCT 2017

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Eric R. Bates

October 30, 2017

$Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!$

Presentation TCT 2017

Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, A. Michael Lincoff

October 30, 2017

Presentation TCT 2017

STEMI Case Presentation: Why the Choice of Patental Therapy Matters

Presenter: Michael S. Lee, Dirk Sibbing, Francesco Franchi

October 30, 2017

Advertisement

Romania Presents: Complications That Can Occur During ACS PCI

CABG Remains the Gold Standard for Left Main Coronary Artery Disease!

Debate: Making the Case for Not Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

NSTEMI Case Presentation: Why the DAPT Pre-load Decision Matters

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Case Resolution: STEMI/ACS

Should Choice of Parenteral Therapy for Primary PCI in STEMI Depend on Vascular Access?

Case Presentation Introduction: STEMI/ACS

Impact of AUC and Public Reporting: Is PCI Now More Appropriate?

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

What Is the Next Quality Indicator to Improve Outcomes in STEMI?

Why I Use Cangrelor for Primary PCI in STEMI!

Why I Prefer Bivalirudin for Primary PCI in STEMI!

A CHIP Case Presentation

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!

STEMI Case Presentation: Why the Choice of Patental Therapy Matters

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content